MODEL42 — Innovate. Invest. Extend.
Partner with usFor investors

07 Contact us

Start the right conversation.

Investors and partners each have their own short application, so the first discussion starts from the right context. Six short fields — no documents needed at this stage.

  1. Choose your pathInvestor or partner — six short fields.
  2. We receive it at onceThe application goes straight to the Model42 team.
  3. A preliminary discussionModel42 may contact you to arrange a first, non-binding conversation.
info@model42.ae www.model42.ae +971 52 234 05 32

Dubai · UAEICTS Training Center, 25A St, Al Quoz Industrial Area 3

Moscow · RussiaPresident Hotel, 24 Bolshaya Yakimanka St

Investor type *
Main interest *

Sent straight to the Model42 team. Prefer email? Write to info@model42.ae.

Almost done

Press «Send» in your email app.

Your application is written and addressed to info@model42.ae. Model42 may contact you about your enquiry. If no email window opened, copy the text and send it to info@model42.ae.

Our offices

Two cities. One platform.

From the Gulf to Eurasia: Model42 works from Dubai and Moscow.

Dubai · UAEHead office Moscow · RussiaCIS & Russia office

3,700 kmabout 5 hours by air

Dubai

Head office · UAE

ICTS Training Center, 25A St, Al Quoz Industrial Area 3

--:--local time

Open in Google Maps

Moscow

CIS & Russia office

President Hotel, 24 Bolshaya Yakimanka St

--:--local time

Open in Google Maps

Important information

  • Document statusThis website is for informational and marketing purposes only. It does not constitute a public offer, investment recommendation, or medical or legal advice.
  • Plans and forecastsInformation on plans, markets, potential revenues and asset values contains forward-looking statements and does not guarantee future results. Recipients should conduct their own due diligence.
  • Medical activitiesModel42 does not independently provide medical or pharmaceutical services. Such services are provided only by separately licensed entities and professionals under the laws of the relevant jurisdiction.
  • Technology, data and AIDescribing a technology does not imply confirmed efficacy, safety or regulatory approval in any market. Data and AI tools are used only with the necessary consents and in compliance with applicable law.